Forecast 2023
¥0.00
Forecast 2025
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
Forecast 2025
¥0.00
Forecast 2030
TopGraphs Quality Ranking
Underperform
Company Info
P/E
0.00
Beta
0.29
Price-to-book Ratio
1.69
Market Cap
2,700.24B
TEV
3,284.57 B
Dividend
¥73.94
Div Yld
4.91%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
¥2,643.33
Industry
Country
Website
Astellas Pharma Price Chart
1M
3M
YTD
1Y
2Y
5Y
10Y
20Y
Astellas Pharma Stock Forecast 2023
¥2,025.00
In the last five quarters, Astellas Pharma’s Price Target has fallen from ¥3,388.88 to ¥2,643.33 - a -22% decrease.
34.46%
Last update: 04/28/2024
Highest Price Target ¥3,170.00
Average Price Target ¥2,025.00
Lowest Price Target ¥1,200.00
Astellas Pharma Stock Prediction 2025
Astellas Pharma Stock Forecast 2030
P/E
0.00
Beta
0.29
Price-to-book Ratio
1.69
Market Cap
2,700.24B
TEV
3,284.57 B
Dividend
¥73.94
Div Yld
4.91%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
¥2,643.33
Industry
Country
Website
Astellas Pharma Analyst Ratings Frequently Asked Questions
Who are the analysts watching Astellas Pharma Inc.?
The following analysts have recently covered Astellas Pharma:
BofA Global Research
CFRA Equity Research
Citigroup Inc
Citigroup Inc. Research
Daiwa Securities Co. Ltd.
Goldman Sachs
J.P. Morgan
Jefferies LLC
Marktfeld
Marusan Securities Co. Ltd.
Mizuho Securities Co., Ltd.
Morgan Stanley
Nomura Securities Co. Ltd.
Pathology Associates Co., Ltd.
Sanford C. Bernstein & Co., LLC
SMBC NIKKO
UBS Investment Bank
Tokai Tokyo Intelligence Laboratory Co., Ltd.
Macquarie Research
(This information refers to the last 90 days.)
Who are the sell-side analysts watching Astellas Pharma Inc.?
The following sell-side analysts have recently covered Astellas Pharma:
Mamegano, Koichi
Bahari, Hazim
Yamaguchi, Hidemaru
Hashiguchi, Kazuaki
Ueda, Akinori
Wakao, Seiji
Barker, Stephen
Paraskevopoulos, Michail
Tsuzuki, Shinya
Muraoka, Shinichiro
Büchner, Dion Stéfan
Sogi, Miki
Wada, Hiroshi
Akahane, Takashi
Haruta, Kasumi
Ohno, Tsuyoshi
Matsubara, Hiroyuki
Ren, Tony
(This information refers to the last 90 days.)